Related references
Note: Only part of the references are listed.Time for Food: The Intimate Interplay between Nutrition, Metabolism, and the Circadian Clock
Gad Asher et al.
CELL (2015)
Poly-ADP-ribosylation signaling during DNA damage repair
Barbara Golia et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2015)
Epigenomes as therapeutic targets
Christopher A. Hamm et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Poly(ADP-ribose) polymerases as modulators of mitochondrial activity
Peter Bai et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities
Amos A. Fatokun et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Review of Poly (ADP-ribose) Polymerase (PARP) Mechanisms of Action and Rationale for Targeting in Cancer and Other Diseases
Julio C. Morales et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2014)
Poly(ADP-ribose) polymerases in double-strand break repair: Focus on PARP1, PARP2 and PARP3
Carole Beck et al.
EXPERIMENTAL CELL RESEARCH (2014)
Investigation of Poly (ADP-Ribose) Polymerase-1 Genetic Variants as a Possible Risk for Allergic Rhinitis
Ahmet Ozaydin et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2014)
Coupling of NAD metabolism, sirtuins and lifespan
Eric Verdin
NATURE MEDICINE (2014)
Automodification switches PARP-1 function from chromatin architectural protein to histone chaperone
Uma M. Muthurajan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Augmentation of NAD+ by NQO1 attenuates cisplatin-mediated hearing impairment
H-J Kim et al.
CELL DEATH & DISEASE (2014)
Inputs and outputs of poly(ADP-ribosyl)ation: Relevance to oxidative stress
Csaba Hegedus et al.
REDOX BIOLOGY (2014)
n-3 Long-chain PUFA reduce allergy-related mediator release by human mast cells in vitro via inhibition of reactive oxygen species
Lieke W. J. van den Elsen et al.
BRITISH JOURNAL OF NUTRITION (2013)
PARP-1 and gene regulation: Progress and puzzles
W. Lee Kraus et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
Nutritional lipidomics: Molecular metabolism, analytics, and diagnostics
Jennifer T. Smilowitz et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2013)
Oxidative Stress and Erythrocyte Membrane Alterations in Children with Autism: Correlation with Clinical Features
Alessandro Ghezzo et al.
PLOS ONE (2013)
The Role of PARP-1 and PARP-2 Enzymes in Metabolic Regulation and Disease
Peter Bai et al.
CELL METABOLISM (2012)
Poly(ADP-ribose) polymerase-2: emerging transcriptional roles of a DNA-repair protein
Magdolna Szanto et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Role of fatty acid-based functional lipidomics in the development of molecular diagnostic tools
Carla Ferreri et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2012)
Role of poly(ADP-ribose) polymerases in the regulation of inflammatory processes
Peter Bai et al.
FEBS LETTERS (2012)
Structures of the Human Poly (ADP-Ribose) Glycohydrolase Catalytic Domain Confirm Catalytic Mechanism and Explain Inhibition by ADP-HPD Derivatives
Julie A. Tucker et al.
PLOS ONE (2012)
Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells
Giovanna D'Onofrio et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Histone ADP-ribosylation in DNA repair, replication and transcription
Simon Messner et al.
TRENDS IN CELL BIOLOGY (2011)
PARP-1 Regulates Chromatin Structure and Transcription through a KDM5B-Dependent Pathway
Raga Krishnakumar et al.
MOLECULAR CELL (2010)
Cellular Metabolic Stress: Considering How Cells Respond to Nutrient Excess
Kathryn E. Wellen et al.
MOLECULAR CELL (2010)
Dietary n-6 and n-3 polyunsaturated fatty acids: From biochemistry to clinical implications in cardiovascular prevention
Gian Luigi Russo
BIOCHEMICAL PHARMACOLOGY (2009)
Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale
Philip C. Calder
BIOCHIMIE (2009)
A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial
David A. Morrow et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2009)
Dietary docosahexaenoic and eicosapentaenoic acid: Emerging mediators of inflammation
Robert S. Chapkin et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2009)
Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease
Pal Pacher et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
417-2α-Tocopherol and ascorbic acid attenuates the ribavirin-induced decrease of eicosapentaenoic acid in erythrocyte membrane in chronic hepatitis C patients
Keisuke Hino et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors
P Jagtap et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
The therapeutic potential of poly(ADP-ribose) polymerase inhibitors
L Virág et al.
PHARMACOLOGICAL REVIEWS (2002)
Share Paper
